Self-evaluations of antidepressants.
D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003891:Desipramine / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004316:Doxepin / Q000627:therapeutic use; D004341:Drug Evaluation / Q000592:standards; D004359:Drug Therapy, Combination; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008950:MMPI; D008774:Methylphenidate / Q000627:therapeutic use; D009526:Nialamide / Q000627:therapeutic use; D010293:Pargyline / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011581:Psychological Tests; D013223:Statistics as Topic; D013881:Thioridazine / Q000627:therapeutic use; D014191:Tranylcypromine / Q000627:therapeutic use
D000928:Antidepressive Agents; D010919:Placebos; D004316:Doxepin; D000639:Amitriptyline; D008774:Methylphenidate; D014191:Tranylcypromine; D002707:Chlordiazepoxide; D010293:Pargyline; D013881:Thioridazine; D007099:Imipramine; D003975:Diazepam; D009526:Nialamide; D003891:Desipramine; D003913:Dextroamphetamine